Evidence map›Paper›PMID 35637966›Full record

ArticleInternational journal of biological sciences2022

HERC3 directly targets RPL23A for ubiquitination degradation and further regulates Colorectal Cancer proliferation and the cell cycle.

Zhiyuan Zhang, Qi Wu, Meimiao Fang, Yu Liu, Ji Jiang, Qingyang Feng, Ronggui Hu, Jianmin Xu

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Subtype-Specific mInternational journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Research Progress of Ribosomal Proteins in Reproductive Development.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Aging · 2023
    Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zhiyuan ZhangDepartment of General Surgery, Zhongshan Hospital, Fudan University, 200030 Shanghai, China.
Qi WuDepartment of General Surgery, Zhongshan Hospital, Fudan University, 200030 Shanghai, China.
Meimiao FangState Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, 200030 Shanghai, China.
Yu LiuDepartment of General Surgery, Zhongshan Hospital, Fudan University, 200030 Shanghai, China.
Ji JiangCollege of Life Sciences, Shanghai Normal University, Shanghai 200234, China.
Qingyang FengDepartment of General Surgery, Zhongshan Hospital, Fudan University, 200030 Shanghai, China.
Ronggui HuState Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, 200030 Shanghai, China.
Jianmin XuDepartment of General Surgery, Zhongshan Hospital, Fudan University, 200030 Shanghai, China.
Shanghai Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colorectal NeoplasmsRibosomal ProteinsUbiquitin-Protein LigasesCell CycleCell DivisionCell ProliferationHumansUbiquitinationHERC3 protein, humanRibosomal ProteinsRPL23a protein, humanUbiquitin-Protein Ligasescell cyclecolorectal cancerp21ubiquitin

Identifiers

PMID35637966
PMCPMC9134906
OpenAlexW4285148186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.